Chemo101.com (Chemo101) was developed by the partners of The Conduit Group, a consulting agency specializing in the areas of strategic human capital management, merger and acquisition analysis, and product reimbursement strategies for the pharmaceutical, biotech, and medical device industries.  Chemo101 serves to focus educational direction for patients on the various aspects of chemotherapeutic treatment and the potential financial implications of the regimens.

Chemo101 is an interactive website dedicated to cancer patients, their caregivers, and the mid level health care practitioners (MLP) that carry out the treating physician orders.   Chemo101 provides cancer stricken patients and their caregivers with educational and practical information concerning the various single chemotherapeutic agents, combination drug treatment regimens, and supportive care products.  The website navigates patients and caregivers through the various medical terminologies, treatment side effects, and the financial implications (insurance rules and regulations) to consider before starting therapy.  Additionally, Chemo101 provides patient support and financial support resources to help with the emotional, physical, and financial burdens that can be caused by the diagnosis and subsequent treatment of cancer. 

Kristin Gustafson, President and Founder:

Kristin Gustafson (KG) is the President and Founder of Chemo101. She started Chemo101 in April of 2010 to help advocate for patient participation in their cancer treatments and create a financial information resource around chemotherapy drugs. With over 10+ years in the pharmaceutical industry, KG wanted to help patients understand basic medical terminology and improve their conceptual understanding of their cancer diagnosis and treatment.

As an executive and human resources professional, KG brings 20 plus years experience managing and developing high growth organizations for expansions, product launches, and company acquisitions. Focusing on the human capital component of such businesses as MGI Pharma, Pharmacyclics, Cochlear, American Cancer Society, Allos Therapeutics and other consulting projects in the pharmaceutical and medical device industries.